Biotech China 2014
Biomarkers Summit
Crowne Plaza London
19 New Bridge Street EC4V 6DB
British Airways London Eye, St Paul’s Cathedral, Millennium Bridge, Tate Modern and West End theatre, London
http://www.smi-online.co.uk/events/overview.asp?is=4&ref=3479
With the industry currently realising the benefits to be had from joint R&D projects and key collaborations, it is now estimated that the Biomarker market value will reach over $12.8 Billion dollars by 2012.



Likewise the level of innovation in Biomarker applications and translational science is seeing increasingly rapid growth. With new discoveries being made in every therapeutic category, Biomarkers are promising to drive forward new drug discovery, companion diagnostics, and to wholly improve patient outcomes.

Schedule of Presentations:

Monday, January 31, 2011
08:30:00 Registration & Coffee
08:50:00 STREAM ONE
08:50:00 STREAM TWO
08:55:00 BIOMARKERS IN ONCOLOGY
08:55:00 BIOMARKERS IN IMMUNOLOGY AND CNS
09:00:00 Chairman's opening remarks Hans Winkler
09:00:00 Chairman's opening remarks Mark Fidock
09:10:00 STREAM TWO | IDENTIFICATION AND CHARACTERISATION OF CANDIDATE BIOMARKERS FOR A NOVEL KINASE INHIBITOR FOR TREATMENT OF AUTOIMMUNE DISEASES Andrew Payne
09:10:00 STREAM ONE | APPLICATION OF PHARMACODYNAMIC MARKERS OF NEDD8 PATHWAY INHIBITION TO ASSESS MLN4924 ACTIVITY IN PHASE I TRIALS Peter Smith
09:50:00 STREAM ONE | PRECLINICAL CANCER MODELS USED IN DRUG DISCOVERY AND TRANSLATIONAL ONCOLOGY Robert Wilkinson
09:50:00 STREAM TWO | DEVELOPING PROOF-OF-PHARMACOLOGY BIOMARKERS Mark Fidock
10:30:00 STREAM ONE | LARGE-SCALE PROTEOME PROFILING OF BREAST AND COLORECTAL TUMOURS Metodi Metodiev
10:30:00 STREAM TWO | BIOMARKERS FOR CHRONIC HCV - PREDICTING RESPONSE TO THERAPY Matthew L. Albert
11:10:00 Morning coffee
11:10:00 Morning coffee
11:40:00 STREAM ONE | TRI-FUNCTIONAL CAPTURE COMPOUNDS: A NEW ROUTE IN FUNCTIONAL PROTEOMICS TO TARGET BIOMARKER-RELEVANT PROTEINS Mathias Dreger
11:40:00 STREAM TWO | BIOMARKERS FOR INHALED ANTI-INFLAMMATORY THERAPIES – SAMPLING THE LUNG Iain Kilty
12:20:00 STREAM ONE | USE OF PROTEOMICS TO DISCOVER CELL SURFACE MARKERS OF APOPTOSIS Huseyin Mehmet
12:20:00 STREAM TWO | FINDING THE PATTERNS: EXECUTING AND INTERPRETING A BIOMARKER PROGRAM Sabine Küsters
13:00:00 Networking lunch
13:00:00 Networking lunch
14:00:00 STREAM TWO | MINIATURISED MULTIPLEXED IMMUNOASSAYS FOR BIOMARKER DISCOVERY AND VALIDATION Thomas Joos
14:00:00 STREAM ONE | DISCOVERY AND APPLICATION OF PREDICTIVE BIOMARKERS FOR MAGE-A3 CANCER IMMUNOTHERAPY Fernando Ulloa-Montoya
14:40:00 STREAM TWO | BIOMARKER RESEARCH IN DEPRESSION: PART I Mette Jensen
14:40:00 STREAM ONE | APPLICATION OF BIOMARKERS IN EARLY DEVELOPMENT Hans Winkler
15:20:00 Afternoon tea
15:20:00 Afternoon tea
15:50:00 STREAM TWO | BIOMARKER RESEARCH IN DEPRESSION : PART II Jennifer Larsen
15:50:00 STREAM ONE | NON-FLUID BIOMARKERS Karen Asin
16:30:00 STREAM ONE | URINARY BIOMARKERS IN THE CLINICAL PROGNOSIS AND EARLY DETECTION OF ACUTE KIDNEY INJURY (AKI) Hans Winkler, Mark Fidock, Patrick Murray
16:30:00 STREAM TWO | EXPERIMENTAL NEUROSCIENCE - BETTER INTEGRATION OF NOVEL DISCOVERIES IN CLINICAL TRIALS Jens Mikkelsen
17:10:00 Chairman’s Closing Remarks and Close of Day One
Tuesday, February 1, 2011
08:30:00 Registration & Coffee
09:00:00 Chairman's Opening Remarks
09:10:00 ISSUES IN STATISTICAL VALIDATION OF BIOMARKERS AS SURROGATE ENDPOINTS IN CLINICAL TRIALS Ziad Taib
09:50:00 CREATION OF BIOMARKER EVIDENCE MAPS TO ENABLE EXPLORATORY DEVELOPMENT Ann Hastings
10:30:00 STRATIFICATION BIOMARKERS FOR DISEASE POPULATIONS IDENTIFY UNDERLYING MECHANISMS OF DISEASE Renee Kenney
11:10:00 Morning Coffee
11:30:00 THE APPLICATION OF INFORMATICS TO BIOMARKER DEVELOPMENT Hugh Salter
12:10:00 BIOSTATISTICS CHALLENGES OF BIOMARKER IDENTIFICATION FOR PERSONALISED MEDICINE Andreas Schuppert
12:50:00 Networking Lunch
13:50:00 PERSONALISED MEDICINES: TURNING PROMISE INTO REALITY Louise Leong
14:30:00 RAPID BIOMARKER VALIDATION AND DEVELOPMENT IN TRANSLATIONAL RESEARCH Hayley Whitaker
15:10:00 TRANSLATIONAL BIOMARKERS IN THE DEVELOPMENT OF NOVEL ANALGESIC DRUGS Ge Ruigt
15:30:00 Afternoon Tea
16:10:00 NEW AND INNOVATIVE AND WAYS OF CONDUCTING BIOMARKER R&D Shawnmarie Mayrand-Chung
16:50:00 STRATIFICATION BIOMARKERS IN PERSONALISED MEDICINE Jean-Luc Sanne
17:30:00 Chairman’s Closing Remarks and Close of Day Two
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.